Global DNA Diagnostics Market Trends, Size, Development, Growth and Demand Forecast to 2022 by P&S Market Research
The global DNA diagnostics market is growing due to technological advancement, and cost effective diagnostic solution. The growing adoption of new technologies such as polymerase chain reaction, next generation sequencing, and microarray is also posing an opportunity for the global market. Among the various products, the instrument segment leads the market, due to improved healthcare facilities, and its inexpensive cost structure. However, the services and software segment is expected to grow with the fastest rate during the forecast period. Among the various technologies, the PCR segment accounted for the largest share in the global market of DNA diagnostics, due to its frequent usage in diagnostic procedures, such as sample separation, isolation, and preparation of the DNA sample. And among the various applications, the oncology segment dominated the market of DNA diagnostic, due to increasing prevalence of chronic diseases and growing geriatric population.
Explore more about “DNA Diagnostics Market” at: https://www.psmarketresearch.com/market-analysis/dna-diagnostics-market
The unexplored market in the DNA diagnostics industry of the developing economies is creating abundant growth opportunities for the global market. The product launches, and collaborations and partnerships are some of the major trends witnessed in the global market. DNA diagnosis technique helps healthcare professionals to identify various chronic and infectious diseases, such as cancer, hepatitis, tuberculosis and human immunodeficiency virus (HIV) accurately and cost effectively.
Some of the factors driving the growth of the global DNA diagnostics market are growing prevalence of chronic and infectious diseases, increasing adoption of personalized medicine, improving healthcare infrastructure in developing countries, and growing geriatric population. In addition, the increasing research and development in the field of biotechnology, increasing healthcare expenditure, and increasing demand for prenatal screening and new born testing are also fueling the growth of the global market. However, the high cost involved in research and development, strict regulatory requirement and lack of reimbursement policies are some of the factors, restraining the growth of the global DNA diagnostics market.
Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the companies operating in the global DNA diagnostics market are Sysmex Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Bayer Diagnostic, Illumina Inc., Gen-Probe Inc., Cephide Inc., Johnson and Johnson, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., and Novartis AG.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: enquiry@psmarketresearch.com
